sˈɑːɹɡɹɐmˌoʊstɪm ɪz pɹaɪmˈɛɹᵻli jˈuːzd fɔːɹ mˈaɪɪlˌɔɪd ɹˌiːkˌɑːnstɪtˈuːʃən ˈæftɚɹ ˌɔːɾoʊlˈɑːɡəs ɔːɹ ˈæloʊdʒnˌeɪk bˈoʊn mˈæɹoʊ tɹænsplɐntˈeɪʃən.
Sargramostim is primarily used for myeloid reconstitution after autologous or allogeneic bone marrow transplantation.